Cape Ann Savings Bank’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-7,854
Closed -$555K 66
2016
Q3
$555K Sell
7,854
-4,859
-38% -$354K 0.78% 36
2016
Q2
$940K Sell
12,713
-101
-0.8% -$6.98K 1.29% 24
2016
Q1
$832K Sell
12,814
-232
-2% -$15.8K 1.15% 31
2015
Q4
$1.01M Buy
13,046
+260
+2% +$20.7K 1.38% 24
2015
Q3
$1.05M Hold
12,786
1.57% 19
2015
Q2
$1.13M Sell
12,786
-73
-0.6% -$6.7K 1.6% 20
2015
Q1
$1.14M Sell
12,859
-122
-0.9% -$10.8K 1.59% 21
2014
Q4
$1.08M Sell
12,981
-750
-5% -$62.2K 1.55% 23
2014
Q3
$1.16M Sell
13,731
-28
-0.2% -$2.27K 1.72% 22
2014
Q2
$1.12M Sell
13,759
-78
-0.6% -$6.13K 1.61% 23
2014
Q1
$1.05M Sell
13,837
-134
-1% -$9.76K 1.73% 22
2013
Q4
$1.01M Buy
13,971
+61
+0.4% +$4.24K 1.62% 22
2013
Q3
$956K Sell
13,910
-67
-0.5% -$4.43K 1.64% 23
2013
Q2
$885K Buy
+13,977
New +$909K 1.48% 25

Other funds holding NVS

Cape Ann Savings Bank's NVS Position: Q4 2016 in Review

Cape Ann Savings Bank sold out of Novartis (NVS) in Q4 2016, closing a stake of 7,854 shares — an estimated $555K sold.

Cape Ann Savings Bank first reported a position in NVS in Q2 2013 and held it in 14 quarters. The position peaked at $1.16M in Q3 2014. 904 funds tracked by Wall St. Rank hold NVS as of Q4 2016.

  • Cape Ann Savings Bank reported no remaining Novartis position as of Q4 2016 after selling out during the quarter.
  • Cape Ann Savings Bank sold 7,854 Novartis shares in Q4 2016, an estimated $555K.
  • Cape Ann Savings Bank first reported a position in Novartis in Q2 2013 and held it in 14 quarters.
  • Cape Ann Savings Bank's Novartis position peaked at $1.16M in Q3 2014.
  • 904 funds tracked by Wall St. Rank held Novartis as of Q4 2016.

Based on Cape Ann Savings Bank's 13F filing for Q4 2016, filed 2 Feb 2017.